Who
Kenneth Song
Other role
Company insider
Files Form 4 as: Other, Freenome; President and Chief Executive, RayzeBio.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 17 Nov 2023
- Last trade
- 20 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jul 2026filed 24 Jul 2026 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code C | —30,000 | filing |
| 20 Jul 2026filed 24 Jul 2026 | FRNM Freenomeoption or derivative · Diagnostics & Labs | SEC FORM 4 Code C | —30,000 | filing |
| 20 Jul 2026filed 24 Jul 2026 | FRNM Freenomeoption or derivative · Diagnostics & Labs | SEC FORM 4 Code C | —30,000 | filing |
| 20 Jul 2026filed 24 Jul 2026 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code C | —30,000 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBiooption or derivative | SEC FORM 4 Code D | —758,607 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBiooption or derivative | SEC FORM 4 Code D | —114,763 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBiooption or derivative | SEC FORM 4 Code D | —480,000 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBio | SEC FORM 4 Code D | $101.4M1,622,968 at $62.50 | filing |
| 17 Nov 2023filed 17 Nov 2023 | RayzeBiooption or derivative | SEC FORM 4 Code A | —480,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.